|
1.
|
Avastin
|
Inf Konz 100 mg/4ml
|
Vial 4 ml
|
283.32
|
342.00
|
01.01.2024
|
|
|
L
|
Nein
|
56922001
|
Roche Pharma (Schweiz) AG
|
Bevacizumabum
|
18082
|
15.01.2005
|
- L: 30.06.2026
- L: 30.06.2025
- L: 31.01.2026
|
PM
|
18082.01
18082.02
18082.03
18082.04
18082.05
18082.06
18082.07
18082.08
18082.09
|
R
|
07.16.10.
|
L01FG01
|
|
2.
|
Avastin
|
Inf Konz 400 mg/16ml
|
Vial 16 ml
|
1059.11
|
1224.25
|
01.01.2024
|
|
|
L
|
Nein
|
56922003
|
Roche Pharma (Schweiz) AG
|
Bevacizumabum
|
18082
|
15.01.2005
|
- L: 30.06.2026
- L: 30.06.2025
- L: 31.01.2026
|
PM
|
18082.01
18082.02
18082.03
18082.04
18082.05
18082.06
18082.07
18082.08
18082.09
|
R
|
07.16.10.
|
L01FG01
|
|
3.
|
Bevacizumab-Teva
|
Inf Konz 100 mg/4ml
|
Durchstf 1 Stk
|
257.57
|
312.40
|
01.07.2021
|
|
|
L
|
Nein
|
67886001
|
Teva Pharma AG
|
Bevacizumabum
|
21264
|
01.07.2021
|
- L: 30.06.2026
- L: 30.06.2025
- L: 31.01.2026
|
PM
|
21264.01
21264.02
21264.03
21264.04
21264.05
21264.06
21264.07
21264.08
21264.09
|
BioS
|
07.16.10.
|
L01FG01
|
|
4.
|
Bevacizumab-Teva
|
Inf Konz 400 mg/16ml
|
Durchstf 1 Stk
|
962.84
|
1118.60
|
01.07.2021
|
|
|
L
|
Nein
|
67886002
|
Teva Pharma AG
|
Bevacizumabum
|
21264
|
01.07.2021
|
- L: 30.06.2026
- L: 30.06.2025
- L: 31.01.2026
|
PM
|
21264.01
21264.02
21264.03
21264.04
21264.05
21264.06
21264.07
21264.08
21264.09
|
BioS
|
07.16.10.
|
L01FG01
|
|
5.
|
Mvasi
|
Inf Konz 100 mg/4ml
|
Durchstf 4 ml
|
257.57
|
312.40
|
01.07.2020
|
|
|
L
|
Nein
|
67283001
|
Amgen Switzerland AG
|
Bevacizumabum
|
21084
|
01.07.2020
|
- L: 30.06.2026
- L: 30.06.2025
- L: 31.01.2026
|
PM
|
21084.01
21084.02
21084.03
21084.04
21084.05
21084.06
21084.07
21084.08
21084.09
|
BioS
|
07.16.10.
|
L01FG01
|
|
6.
|
Mvasi
|
Inf Konz 400 mg/16ml
|
Durchstf 16 ml
|
962.84
|
1118.60
|
01.07.2020
|
|
|
L
|
Nein
|
67283002
|
Amgen Switzerland AG
|
Bevacizumabum
|
21084
|
01.07.2020
|
- L: 30.06.2026
- L: 30.06.2025
- L: 31.01.2026
|
PM
|
21084.01
21084.02
21084.03
21084.04
21084.05
21084.06
21084.07
21084.08
21084.09
|
BioS
|
07.16.10.
|
L01FG01
|
|
7.
|
Oyavas
|
Inf Konz 100 mg/4ml
|
Durchstf 4 ml
|
257.57
|
312.40
|
01.08.2021
|
|
|
L
|
Nein
|
67857001
|
Spirig HealthCare AG
|
Bevacizumabum
|
21272
|
01.08.2021
|
- L: 30.06.2026
- L: 30.06.2025
|
PM
|
21272.01
21272.02
21272.03
21272.04
21272.05
21272.06
21272.07
21272.08
|
BioS
|
07.16.10.
|
L01FG01
|
|
8.
|
Oyavas
|
Inf Konz 400 mg/16ml
|
Durchstf 16 ml
|
962.84
|
1118.60
|
01.08.2021
|
|
|
L
|
Nein
|
67857002
|
Spirig HealthCare AG
|
Bevacizumabum
|
21272
|
01.08.2021
|
- L: 30.06.2026
- L: 30.06.2025
|
PM
|
21272.01
21272.02
21272.03
21272.04
21272.05
21272.06
21272.07
21272.08
|
BioS
|
07.16.10.
|
L01FG01
|
|
9.
|
Vegzelma
|
Inf Konz 100 mg/4ml
|
Durchstf 1 Stk
|
257.57
|
312.40
|
01.08.2023
|
|
|
L
|
Nein
|
69166001
|
iQone Healthcare Switzerland SA
|
Bevacizumabum
|
21617
|
01.08.2023
|
- L: 30.06.2026
- L: 30.06.2025
|
PM
|
21617.01
21617.02
21617.03
21617.04
21617.05
21617.06
21617.07
21617.08
|
BioS
|
07.16.10.
|
L01FG01
|
|
10.
|
Vegzelma
|
Inf Konz 400 mg/16ml
|
Durchstf 1 Stk
|
962.84
|
1118.60
|
01.08.2023
|
|
|
L
|
Nein
|
69166002
|
iQone Healthcare Switzerland SA
|
Bevacizumabum
|
21617
|
01.08.2023
|
- L: 30.06.2026
- L: 30.06.2025
|
PM
|
21617.01
21617.02
21617.03
21617.04
21617.05
21617.06
21617.07
21617.08
|
BioS
|
07.16.10.
|
L01FG01
|